LAURA LEAHY: Open Payments
NPI 1548352875 · SEWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,268 in 27 payments from 9 companies in 2025. Trend: 2023 $8,615 · 2024 $17,332 · 2025 $7,268
Consulting: $4,230Travel & lodging: $2,426Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| Emergent BioSolutions Inc. | 8 | $4,835 |
| Janssen Scientific Affairs, LLC | 10 | $1,548 |
| Biogen, Inc. | 1 | $647 |
| Neurocrine BioSciences, Inc. | 1 | $103 |
| Bausch Health US, LLC | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
Products named: SPRAVATO, ZURZUVAE, INGREZZA, APLENZIN, Auvelity, CAPLYTA, COBENFY, REXULTI.
Industry payments across NJ — which companies pay providers there.
